- Home
- CCEC vs QDEL Comparison
CCEC vs QDEL Comparison
Compare CCEC & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CCEC | QDEL |
|---|---|---|
| Founded | 2007 | 1979 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.0B |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | CCEC | QDEL |
|---|---|---|
| Price | $20.22 | $13.48 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 4 |
| Target Price | $23.67 | ★ $28.25 |
| AVG Volume (30 Days) | 13.7K | ★ 1.5M |
| Earning Date | 05-08-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.75% | N/A |
| EPS Growth | N/A | ★ 45.35 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,730,200,000.00 |
| Revenue This Year | $19.82 | $3.51 |
| Revenue Next Year | $39.95 | $3.86 |
| P/E Ratio | $4.82 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $16.77 | $9.92 |
| 52 Week High | $24.83 | $35.58 |
Technical Indicators
Market Signals| Indicator | CCEC | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 39.00 | 51.04 |
| Support Level | $20.05 | $12.87 |
| Resistance Level | $21.79 | $17.78 |
| Average True Range (ATR) | 0.93 | 1.05 |
| MACD | -0.28 | -0.01 |
| Stochastic Oscillator | 2.12 | 31.71 |
Price Performance
Historical ComparisonAbout CCEC Capital Clean Energy Carriers Corp.
Capital Clean Energy Carriers Corp is an international shipping company. It is the platform of gas carriage solutions with a focus on the energy transition. The company owns 20 high-specification vessels, including 12 latest-generation LNG carriers (LNG/Cs) and eight legacy Neo-Panamax container vessels.
About QDEL QuidelOrtho Corporation
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.